Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAGHAV MOHINDRA

Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine

NPI
1427210426
CMS profile
245981
Location
PRESCOTT VALLEY, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$2,026.45

122 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,026.45 122

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAGHAV MOHINDRA

NPI 1427210426 · CMS profile ID 245981

Allopathic & Osteopathic Physicians / Internal Medicine / Geriatric Medicine

PRESCOTT VALLEY, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427210426?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAGHAV MOHINDRA, NPI 1427210426, CMS profile ID 245981. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427210426?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). RAGHAV MOHINDRA, NPI 1427210426, CMS profile ID 245981. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427210426?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
RAGHAV MOHINDRA, NPI 1427210426, CMS profile ID 245981, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1427210426?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

122 matching records · $2,026.45 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 122 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 122.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $16.2908/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722039017 CMS
Allergan, Inc. $13.2607/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723803765 CMS
Radius Health, Inc. $45.9107/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746281509 CMS
Abbott Laboratories $15.6107/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747350867 CMS
Amarin Pharma Inc. $18.6407/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740085465 CMS
GlaxoSmithKline, LLC. $15.6707/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738848197 CMS
Amgen Inc. $14.8707/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741268265 CMS
Allergan, Inc. $10.3507/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723803763 CMS
Janssen Pharmaceuticals, Inc $18.6807/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719360955 CMS
Sunovion Pharmaceuticals Inc. $22.7807/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748442927 CMS
Abbott Laboratories $12.8307/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747347415 CMS
Radius Health, Inc. $26.3306/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746281493 CMS
Lilly USA, LLC $14.6106/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728592727 CMS
Novo Nordisk Inc $12.4406/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744774041 CMS
AstraZeneca Pharmaceuticals LP $11.2306/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738698603 CMS
Allergan, Inc. $9.5106/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723803761 CMS
PFIZER INC. $13.6806/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743735939 CMS
AbbVie Inc. $14.6606/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722039015 CMS
GlaxoSmithKline, LLC. $3.0106/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738663033 CMS
Amgen Inc. $23.8806/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741268269 CMS
AbbVie Inc. $17.6406/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722039013 CMS
GlaxoSmithKline, LLC. $15.0706/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738545641 CMS
Amarin Pharma Inc. $16.1306/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740003879 CMS
AbbVie Inc. $11.8005/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722039011 CMS
Astellas Pharma US Inc $13.0905/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718358479 CMS
GlaxoSmithKline, LLC. $11.1205/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738710025 CMS
Janssen Pharmaceuticals, Inc $13.9105/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719360959 CMS
Amarin Pharma Inc. $15.1204/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740003899 CMS
AstraZeneca Pharmaceuticals LP $11.5004/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738670459 CMS
GlaxoSmithKline, LLC. $14.4604/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738545477 CMS
Kowa Pharmaceuticals America, Inc. $11.4704/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716725453 CMS
Novo Nordisk Inc $14.2604/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744667737 CMS
AstraZeneca Pharmaceuticals LP $13.6704/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738675159 CMS
Abbott Laboratories $18.8803/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749027151 CMS
AbbVie Inc. $14.7303/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722039009 CMS
AstraZeneca Pharmaceuticals LP $13.5803/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738676519 CMS
GlaxoSmithKline, LLC. $10.6403/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738689201 CMS
PFIZER INC. $12.8403/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743428011 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.9402/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720530061 CMS
Amarin Pharma Inc. $5.6302/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740003875 CMS
Novartis Pharmaceuticals Corporation $16.6202/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726028823 CMS
Novo Nordisk Inc $11.5002/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744634191 CMS
Watermark Medical, Inc. $173.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 753318231 CMS
Allergan, Inc. $2.1802/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723803759 CMS
Amarin Pharma Inc. $5.4402/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740003897 CMS
Astellas Pharma US Inc $22.3302/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718358477 CMS
PFIZER INC. $12.4202/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743764205 CMS
UCB, Inc. $11.7702/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746073457 CMS
PFIZER INC. $15.4302/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743764839 CMS
GlaxoSmithKline, LLC. $12.1702/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738544265 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,617.70 206
PY2020 $2,026.45 122
PY2021 $3,365.95 190
PY2022 $2,277.34 136
PY2023 $3,566.72 57
PY2024 $603.79 30
PY2025 $906.93 38

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $1,279,373.21 28
PY2022 Principal investigator $667,269.00 16

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $2,000.00 12/12/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 2B DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED PARALLEL GROUP DOSE RANGING STUDY TO EVALUATE VIROLOGICAL RESPONSE AND SAFETY OF ORAL PF07817883 IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 No dispute reported 06/30/2026 1046418873
Principal investigator 1 PFIZER INC. $6,600.00 12/06/2023 Non-covered Recipient Entity
Epic Medical Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046364849
Principal investigator 1 PFIZER INC. $394,385.72 11/15/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046404151
Principal investigator 1 PFIZER INC. $3,200.00 11/11/2023 Non-covered Recipient Entity
Epic Medical Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046380677
Principal investigator 1 PFIZER INC. $5,500.00 11/09/2023 Non-covered Recipient Entity
Epic Medical Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046369529
Principal investigator 1 PFIZER INC. $15,090.00 10/18/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046397353
Principal investigator 1 PFIZER INC. $19,092.00 09/23/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 2B DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED PARALLEL GROUP DOSE RANGING STUDY TO EVALUATE VIROLOGICAL RESPONSE AND SAFETY OF ORAL PF07817883 IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 No dispute reported 06/30/2026 1046390197
Principal investigator 1 PFIZER INC. $347,752.00 08/22/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046431465
Principal investigator 1 PFIZER INC. $3,750.00 08/17/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046401931
Principal investigator 1 PFIZER INC. $2,500.00 08/09/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046402421
Principal investigator 1 PFIZER INC. $6,936.00 06/29/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046524649
Principal investigator 1 PFIZER INC. $26,112.00 06/22/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046373089
Principal investigator 1 PFIZER INC. $12,240.00 06/16/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046505479
Principal investigator 1 PFIZER INC. $20,808.00 06/14/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046508995
Principal investigator 1 PFIZER INC. $56,712.00 06/03/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046530543
Principal investigator 1 PFIZER INC. $17,952.00 05/25/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046522615
Principal investigator 1 PFIZER INC. $2,856.00 05/16/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046436773
Principal investigator 1 PFIZER INC. $21,000.00 04/27/2023 Non-covered Recipient Entity
Epic Medical Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046437165
Principal investigator 1 PFIZER INC. $459.00 03/09/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046450031
Principal investigator 1 PFIZER INC. $146,421.00 02/28/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046460385
Principal investigator 1 PFIZER INC. $825.62 02/28/2023 Non-covered Recipient Entity
EPIC MEDICAL RESEARCH SURPRISE
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046531727
Principal investigator 1 PFIZER INC. $821.96 02/28/2023 Non-covered Recipient Entity
EPIC MEDICAL RESEARCH SURPRISE
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046531795
Principal investigator 1 PFIZER INC. $1,512.81 02/28/2023 Non-covered Recipient Entity
EPIC MEDICAL RESEARCH SURPRISE
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046532521
Principal investigator 1 PFIZER INC. $12,270.30 02/28/2023 Non-covered Recipient Entity
EPIC MEDICAL RESEARCH SURPRISE
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046533727
Principal investigator 1 PFIZER INC. $678.40 02/22/2023 Non-covered Recipient Entity
Epic Medical Research Surprise
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 2 RANDOMIZED DOUBLEBLIND 2ARM STUDY TO INVESTIGATE A REPEAT 5DAY COURSE OF NIRMATRELVIRRITONAVIR COMPARED TO PLACEBORITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY No dispute reported 06/30/2026 1046418141
Principal investigator 1 PFIZER INC. $2,148.80 02/18/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046368337
Principal investigator 1 PFIZER INC. $29,416.80 02/07/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046458827
Principal investigator 1 PFIZER INC. $120,332.80 01/12/2023 Non-covered Recipient Entity
Epic Medical Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER No dispute reported 06/30/2026 1046546851